1 | read more sibylla biotech | | | | | | | 5 | 0.83% |
2 | discovery collaboration with ono | | | | | | | 3 | 0.50% |
3 | collaboration with ono pharmaceutical | | | | | | | 3 | 0.50% |
4 | folding simulations oneiros ai | | | | | | | 3 | 0.50% |
5 | simulations oneiros ai platform | | | | | | | 3 | 0.50% |
6 | sibylla biotech appoints sonia | | | | | | | 2 | 0.33% |
7 | more sibylla biotech appoints | | | | | | | 2 | 0.33% |
8 | drug discovery collaboration with | | | | | | | 2 | 0.33% |
9 | with ono pharmaceutical in | | | | | | | 2 | 0.33% |
10 | ono pharmaceutical in central | | | | | | | 2 | 0.33% |
11 | university of trento and | | | | | | | 2 | 0.33% |
12 | biotech selected by nature | | | | | | | 2 | 0.33% |
13 | appoints sonia poli as | | | | | | | 2 | 0.33% |
14 | biotech appoints sonia poli | | | | | | | 2 | 0.33% |
15 | selected by nature among | | | | | | | 2 | 0.33% |
16 | in the lifescience sector | | | | | | | 2 | 0.33% |
17 | by nature among the | | | | | | | 2 | 0.33% |
18 | the lifescience sector sibylla | | | | | | | 2 | 0.33% |
19 | 2024 – sibylla biotech | | | | | | | 2 | 0.33% |
20 | sibylla biotech raises €23 | | | | | | | 2 | 0.33% |
21 | and expand technology platform | | | | | | | 2 | 0.33% |
22 | startups in the world | | | | | | | 2 | 0.33% |
23 | best startups in the | | | | | | | 2 | 0.33% |
24 | series a to advance | | | | | | | 2 | 0.33% |
25 | a to advance protein | | | | | | | 2 | 0.33% |
26 | to advance protein degradation | | | | | | | 2 | 0.33% |
27 | advance protein degradation by | | | | | | | 2 | 0.33% |
28 | protein degradation by folding | | | | | | | 2 | 0.33% |
29 | pipeline and expand technology | | | | | | | 2 | 0.33% |
30 | eight best startups in | | | | | | | 2 | 0.33% |
31 | 2023 – sibylla biotech | | | | | | | 2 | 0.33% |
32 | programs partnerships about our | | | | | | | 2 | 0.33% |
33 | spagnolli appointed as cto | | | | | | | 2 | 0.33% |
34 | and the university of | | | | | | | 2 | 0.33% |
35 | vision mission impact technology | | | | | | | 2 | 0.33% |
36 | mission impact technology ppifit | | | | | | | 2 | 0.33% |
37 | sibylla biotech appoints dominique | | | | | | | 2 | 0.33% |
38 | oneiros ai platform drug | | | | | | | 2 | 0.33% |
39 | ai platform drug discoverydevelopment | | | | | | | 2 | 0.33% |
40 | as executive chairman of | | | | | | | 2 | 0.33% |